Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Randomized, Parallel-controlled, Superiority Clinical Trial Evaluating the Safety and Efficacy of Single-use Peripheral Intravascular Shock Wave Catheters Combined With Intravascular Shock Wave Therapy Devices for Peripheral Artery Calcified Lesions.

NCT07839143 is registered in ClinicalTrials.gov with Shanghai Bluesail Boyuan Medical Technology Co., Ltd. as lead sponsor.

NCT NCT07839143
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07839143 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Randomized, Parallel-controlled, Superiority Clinical Trial Evaluating the Safety and Efficacy of Single-use Peripheral Intravascular Shock Wave Catheters Combined With Intravascular Shock Wave Therapy Devices for Peripheral Artery Calcified Lesions.
Lead sponsor
Shanghai Bluesail Boyuan Medical Technology Co., Ltd.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
December 15, 2027
Enrollment
158 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

patients with peripheral artery calcified lesions